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Getting over the teething of new technologies
Knowledge in medicine has always depended on the
investigative tools available at any given time. This explains
that our understanding of pathophysiology has most often
progressed by frog leaps, reflecting the successive techno-
logical innovations bestowed upon the various fields of medi-
cine, such as ours. The integration of new technological
innovations normally follows a standard process whereby the
new tools are first tested and their potential virtues tried out
in sets of pilot and feasibility trials. This preliminary step
normally offers a clearer view of the novel technologies’
actual merits, potential clinical applications and usefulness
for answering outstanding pathophysiological queries.
In the case of uterine Doppler however, we seem to be
still at the first step of this process, dealing today with proof
of principle trials that attempt to delineate the potential uses
and applications of uterine Doppler in gynecology. It some-
times seems that uterine Doppler never succeeded in leaving
the teething stage and either reaching maturity and clinical
usefulness, or falling forever into oblivion. And this is par-
ticularly odd, as in the mean time, Doppler technologies have
become widely available to all of us, being a common
adjunct to most gynecological ultrasound machines available
today.
Menopause and controlled ovarian stimulation (COH):
divergent data with unanswered questions
In 1991, Gangar et al. reported that uterine artery resistance
was high in estrogen deprived menopausal women, but
rapidly decreased after exposure to exogenous estrogens.
This was taken as evidence for the vasodilative properties of
estrogens. We concomitantly made similar findings in young
(20–40-year-old) women prematurely deprived of ovarian
function (de Ziegler et al., 1991). In Gangar’s paper, the
dose of transdermal estrogen used (0.05 mg/24 h) yielded the
relatively low levels of plasma E2 achieved in estrogen
therapy prescribed to menopausal women. In our experimen-
tal paradigm, we used larger amounts (,4-fold greater) of
transdermal E2, ranging from 0.1 to 0.4 mg/24 h, in order to
duplicate the levels of E2 encountered in the menstrual
cycle, including the pre-ovulatory rise. Yet in spite of the
difference in age and doses of transdermal E2 used, the low-
ering effect of estrogen therapy on uterine artery impedance
(PI index measured while on estrogen) was similar. Taken
together, these two studies indicated therefore that maximum
vasodilation of uterine vessels is already achieved by the
relatively low levels of E2 reached with postmenopausal
hormone replacement.
But confusingly, investigators from Gangar’s institution
(including one common co-author) also reported that a size-
able fraction of women undergoing controlled ovarian hyper-
stimulation (COH) had high pulsatility index (PI) values
(.3), in spite of the high E2 levels that characterize COH
(Steer et al., 1992). This latter publication drew a lot of
attention because the authors reported that no pregnancies
occurred in women whose PI readings exceeded 3 on the day
of oocyte retrieval. Logically therefore, these authors rec-
ommended that embryos be cryopreserved and transferred at
a later stage when uterine artery Doppler showed PI ,3.
Unfortunately, these authors failed to underscore the diver-
gence between their highly publicized findings of high PIs in
some women undergoing COH and those (probably less read)
indicating that low levels of E2 induce maximum vasodila-
tion of uterine arteries in menopausal women. This omission
hampered our understanding of the mechanisms at play in
those women whose PI remains high in COH in spite of high
E2 levels. How could it be that minimal amounts of E2
induce a maximal decrease in uterine artery PI values (not
surpassed by higher quantities of E2) when some women
undergoing COH have high PI scores in spite of E2 levels
that largely surpass those archieved with menopausal
therapies? This question drew little attention and remained
unanswered to this date.
The ‘3rd factor hypothesis’ for explaining the low
perfusion cases encountered in COH
The observation that low estrogen levels induce maximal
vasodilation of uterine arteries in women whose ovaries are
Human Reproduction Vol.19, No.11 pp. 2615–2618, 2004 doi:10.1093/humrep/deh470
Advance Access publication October 7, 2004
q European Society of Human Reproduction and Embryology 2615
inactive is in contradiction with findings that a fraction of
women exposed to the high E2 levels of COH retain elevated
uterine artery resistance. To reconcile these seemingly
incompatible observations, we hypothesized that a 3rd ovar-
ian factor, i.e. a factor other than E2 and P, causes the
increase in uterine artery resistance seen in some infertile
women in the menstrual cycle or when undergoing COH
(de Ziegler et al., 1993; de Ziegler 1995). One putative can-
didate for this 3rd ovarian factor affecting uterine perfusion
is the ovarian production of androgens, which is also influ-
enced by the degree and type of gonadotropin stimulation.
According to this ‘3rd factor hypothesis’, if the ovaries are
suppressed, such as with a GnRH agonist (GnRH-a), the
putative factor will be neutralized. This should restore an
ideal perfusion of the uterus when it is under the sole influ-
ence of exogenous hormones. In these women therefore, uter-
ine perfusion should be normal during E2 and P replacement,
as prescribed for frozen embryo transfers (FET) on the model
of replacement cycles originally designed for recipients of
donor oocyte IVF.
On the contrary, if the high uterine artery resistance found
in some infertile women results from an intrinsic uterine fac-
tor (i.e. a lack of response to the vasodilative properties of
E2), Doppler data will remain equally altered during the
menstrual cycle (Goswamy and Steptoe, 1988; Goswamy
et al., 1988), COH and E2 and P replacement cycles pre-
scribed for FET.
The existence of a specific uterine factor responsible of
altering blood perfusion and, in turn, receptivity to embryo
implantation is likely to exist in women whose uteri have
been exposed to radiation therapy. In this latter highly
specific group however, we showed that high E2 levels could
restore normal perfusion and receptivity, at least in some
women (Rio et al., 1994).
Differences in uterine Doppler data linked to fertility
vanishing with time, while Doppler measurements
moved down the vascular tree
Following the original paper by Steer et al. (1992), numerous
groups tried to integrate uterine artery Doppler in their IVF
practice with the intent of singling out women whose chances
of getting pregnant were either nil, or so low that cryopreser-
vation of embryos would be warranted. But no groups could
confirm the existence of a cut-off value, such as that of 3 for
PI proposed by Steer et al. (1992) that allowed barring
certain patients from undergoing fresh embryo transfers
because of predictably poor chances of achieving pregnancy.
On the contrary, a number of articles later reported similar
uterine artery resistance data measured by Doppler on the
day of hCG administration and/or embryo transfer in women
who got pregnant or not through IVF (Yuval, 1995; Schild,
1999; Pierson, 2003). These publications reported uterine
Doppler measurements performed on sub-endometrial vessels
as well as on uterine artery trunks. Admittedly, other publi-
cations persisted in claiming that IVF failures were associ-
ated with uterine perfusion disorders that could be identified
or hinted at by uterine artery Doppler (Kupesic, 2002; Chien
et al., 2004) but without clearly identifying any clinically
usable cut-off value for PI.
It was puzzling to us that papers reporting similar uterine
PI values in IVF patients irrespective of whether they became
pregnant or not, showed low PI values across the board
(Yuval, 1995; Schild, 1999). Hence, it was as if the high PI
values that had been measured in a sizeable fraction of COH
patients, and found to predict poor IVF outcome as reported
by Steer et al., had vanished. Could it be that technical
differences, and notably, improvements in Doppler sensitivity
that allow measurements to be taken further down the uterine
vascular tree, have been responsible for the lack of differ-
ences seen in the latest studies between women who got
pregnant or not? We can’t ascertain this, but it certainly
seems that as technology has become more sophisticated,
the early differences reported between pregnant and non-
pregnant patients undergoing ART have got smaller, if not
vanished altogether, in the recent publications.
3-D power Doppler: a story revisited with quantified
and reproducible measurements
Admittedly, early measurements of endometrial and
sub-endometrial blood flow suffered from methodological
weaknesses, being equipment and operator dependant. The
selection of endometrial and sub-endometrial vessels identi-
fied on color Doppler mode was arbitrary. Hence, extrapol-
ations from PI results implied the assumption (which was far
from proven) that the vessels selected for Doppler measure-
ment were representative of the whole endometrial and
sub-endometrial blood flow.
Yang et al. (1999) attempted to quantify color Doppler
visualization of endometrial and sub endometrial blood flow
by direct computation of power Doppler visualization of
blood flow. The computed index, or Endometrial Power
Doppler Area (EPDA), was based on computer-assisted
identification of color pixels. Using this approach, the authors
observed that women who achieved pregnancy had a signifi-
cantly higher EPDA score (8.8 mm2) than those who did not
(5.8 mm2), whereas uterine artery PI values were similar at
1.65 and 1.67 in these two groups.
Wu et al. (2003) pursued this approach one step further by
analyzing power Doppler findings of endometrial and sub-
endometrial blood flow in 3-D power Doppler reconstruc-
tions. In their hands, 3-D power Doppler analysis was the
best available predictor of IVF outcome. This approach
allowed the whole territory of interest, the endometrium and
sub-endometrial area isolated in an 3-D electronic matrix, to
be reviewed. It revived the interest in uterine blood flow
measurements and the hope of singling out women in whom
embryos need to be cryopreserved and transferred at a later
time.
In a recent publication, Raine-Fenning et al. (2004a) used
quantified 3-D power Doppler angiography for studying
changes in endometrial and sub-endometrial blood flow
occurring during the menstrual cycle. For this, the authors
used a 730 GE-Voluson ultrasound machine with defined
Doppler settings and conducted their analysis on acquired
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3-D power Doppler matrices. The endometrial–stromal
interface was delineated with the help of a specially designed
virtual organ computer-aided image-analysis program
(VOCAL). This approach allows the electronic delineation of
the endometrial volume in which blood flow is analyzed by
quantifying the Doppler signal recorded within the specific
volume. Sub-endometrial blood flow was similarly assessed
in a different volume constructed by shelling a secondary
virtual interface set at an arbitrary distance, 5 mm, from the
defined endometrial–myometrial interface. In each 3-D
volume, endometrial and sub-endometrial, pulsed Doppler
data were expressed as vascular index (VI) reflecting the
percent color pixel over total pixel count, flow index (FI)
reflecting the intensity of the power Doppler signal and
a combination of these two parameters or VFI. Using
this sophisticated technique, Raine-Fenning et al. (2004b)
observed an increase in all parameters of endometrial and
sub-endometrial blood flow in the late follicular phase, peak-
ing 3 days prior to ovulation. This was followed by a
decrease after ovulation with a nadir reached in the mid
luteal phase.
In the current issue of Human Reproduction, Raine-
Fenning et al. (2004c) pursued their study, and compared
their menstrual cycle data obtained in presumably fertile
women with new data mustered in a group of women suffer-
ing from unexplained infertility. They observed that in the
latter group, endometrial and sub-endometrial blood flow was
significantly decreased throughout the menstrual cycle. The
comparison was made in non-smoking controls, as these
authors previously showed that blood flow was significantly
decreased in smokers. The authors concluded that endo-
metrial and sub-endometrial blood flow are significantly
decreased in unexplained infertility, despite similar E2 and
progesterone levels throughout the menstrual cycle.
Back to the future of Doppler studies and the long-lived
pilot trial time
When discovering that 3-D Doppler data could be automati-
cally measured within the electronically designed limits of a
virtual shell volume that precisely delineates a given fraction
of the sub-endometrial tissue as reported by Raine-Fenning
et al. (2004b), c), we were tempted to feel excitement. Yet
once over the astonishment generated by the technological
marvel, Raine-Fenning’s report leaves us a little hanging;
with our desire for an understanding of the mechanisms at
play behind their uterine Doppler findings unsatisfied.
We would have liked to know, for example, whether the
altered perfusion identified in infertile women persisted or
disappeared once their ovarian function was suppressed and
replaced by physiological amounts of exogenous E2 and pro-
gesterone (as done for FET). This would have indicated
whether the factor(s) responsible for the decreased perfusion
was of uterine (intrinsic alteration) or hormonal origin (ovar-
ian factors other than E2 and progesterone such as possibly
androgens).
Raine-Fenning’s data on smoking and uterine perfusion
are also puzzling and in many ways, raise questions about
the true value of Doppler alterations as markers of uterine
receptivity. From their findings, endometrial vascularity is
more profoundly altered in smokers as compared with non-
smokers, than it is in infertile as compared with fertile
women. Should we deduce that smoking has absolute contra-
ceptive effects, or are we forced to speculate that the altered
vascularity due to smoking has different consequences on
fecundity than those affecting infertile women?
In short, we would like to have understood more, so that
our knowledge of the mechanisms at play stops trailing in
the wake of the spectacular marvels of 3-D Doppler technol-
ogy. But Raine-Fenning’s paper tells us that we’ll have to
wait a little longer before these questions are addressed; as in
spite of the technological advancements and the fairly long
uterine Doppler history, we are still dwelling in pilot trial
times, as far as uterine Doppler data are concerned. That,
thanks to 3-D technology, uterine Doppler seems to have
seriously reduced the variability of its measurements is defi-
nitely a matter for rejoicing.
References
Chien LW, Au HK, Chen PL, Xiao J and Tzeng CR (2OO) Assessment of
uterine receptivity by the endometrial-subendometrial blood flow distri-
bution pattern in women undergoing in vitro fertilization-embryo transfer.
Fertil Steril 78,245–251.
de Ziegler D, Bessis R and Frydman R (1991) Vascular resistance of uterine
arteries: physiological effects of estradiol and progesterone. Fertil Steril
55,775–779.
de Ziegler D, Fanchin R, Freitas S and Bouchard P (1993) The hormonal
control of endometrial receptivity in egg donation and IVF: from a two to
a multi-player senario. Acta Eur Fertil 24,147–153.
de Ziegler D (1995) Hormonal control of endometrial receptivity. Hum
Reprod 10,4–7.
Gangar KF, Vyas S, Whitehead M, Crook D, Meire H and Campbell S
(1991) Pulsatility index in internal carotid artery in relation to transdermal
oestradiol and time since menopause. Lancet 338,839–842.
Goswamy RK and Steptoe PC (1988) Doppler ultrasound studies of the uter-
ine artery in spontaneous ovarian cycles. Hum Reprod 3,721–726.
Goswamy RK, Williams G and Steptoe PC (1988) Decreased uterine
perfusion—a cause of infertility. Hum Reprod 3,955–999.
Kupesic S (2001) Clinical implications of sonographic detection of uterine
anomalies for reproductive outcome. Ultrasound Obstet Gynecol 18,
387–400.
Pierson RA (2003) Imaging the endometrium: are there predictors of uterine
receptivity? J Obstet Gynaecol Can 25,360–368.
Raine-Fenning NJ, Campbell BK, Clewes JS and Johnson IR (2003) The
interobserver reliability of ovarian volume measurement is improved with
three-dimensional ultrasound, but dependent upon technique. Ultrasound
Med Biol 29,1685–1690.
Raine-Fenning NJ, Campbell BK, Clewes JS, Kendall NR and Johnson IR
(2004a) The interobserver reliability of three-dimensional power Doppler
data acquisition within the female pelvis. Ultrasound Obstet Gynecol 23,
501–508.
Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS and Johnson IR
(2004b) Quantifying the changes in endometrial vascularity throughout the
normal menstrual cycle with three-dimensional power Doppler angiogra-
phy. Hum Reprod 19,330–338.
Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS and Johnson IR
(2004c) Endometrial and sub-endometrial perfusion are impaired in
women with unexplained subfertility. Hum Reprod 19,.
Rio B, Letur-Konirsch H, de Ziegler D et al. (1994) Full-term pregnancy
with embryos from donated oocytes in a 36-year-old woman allografted
for chronic myeloid leukemia. Bone Marrow Transplant 13,487–488.
Schild RL, Indefrei D, Eschweiler S, Van der Ven H, Fimmers R and
Hansmann M (1999) Three-dimensional endometrial volume calculation
and pregnancy rate in an in-vitro fertilization programme. Hum Reprod
14,1255–1258.
Uterine Doppler studies: technology driven data, or answers to our pathophysiological queries?
2617
Steer CV, Campbell S, Tan SL, Crayford T, Mills C, Mason BA and Collins
WP (1992) The use of transvaginal color flow imaging after in vitro ferti-
lization to identify optimum uterine conditions before embryo transfer.
Fertil Steril 57,372–376.
Wu HM, Chiang CH, Huang HY, Chao AS, Wang HS and Soong YK (2003)
Detection of the subendometrial vascularization flow index by three-
dimensional ultrasound may be useful for predicting the pregnancy rate for
patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 79,
507–511.
Yang JH, Wu MY, Chen CD, Jiang MC, Ho HN and Yang YS (1999)
Association of endometrial blood flow as determined by a modified colour
Doppler technique with subsequent outcome of in-vitro fertilization. Hum
Reprod 14,1606–1610.
Yuval Y, Lipitz S, Dor J and Achiron R (1999) The relationships between
endometrial thickness, and blood flow and pregnancy rates in in-vitro ferti-
lization. Hum Reprod 14,1067–1071.
Submitted on July 15, 2004; accepted on July 20, 2004
D.de Ziegler
2618
